Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. <i>Cancers</i> 2022<i>, 14</i>, 4265
In the original publication [...]
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-12-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/14/24/6160 |
| _version_ | 1797461060163207168 |
|---|---|
| author | Matteo Ponzo Anais Debesset Mélissande Cossutta Mounira Chalabi-Dchar Claire Houppe Caroline Pilon Alba Nicolas-Boluda Sylvain Meunier Fabio Raineri Allan Thiolat Rémy Nicolle Federica Maione Serena Brundu Carina Florina Cojocaru Philippe Bouvet Corinne Bousquet Florence Gazeau Christophe Tournigand José Courty Enrico Giraudo José L. Cohen Ilaria Cascone |
| author_facet | Matteo Ponzo Anais Debesset Mélissande Cossutta Mounira Chalabi-Dchar Claire Houppe Caroline Pilon Alba Nicolas-Boluda Sylvain Meunier Fabio Raineri Allan Thiolat Rémy Nicolle Federica Maione Serena Brundu Carina Florina Cojocaru Philippe Bouvet Corinne Bousquet Florence Gazeau Christophe Tournigand José Courty Enrico Giraudo José L. Cohen Ilaria Cascone |
| author_sort | Matteo Ponzo |
| collection | DOAJ |
| description | In the original publication [...] |
| first_indexed | 2024-03-09T17:14:02Z |
| format | Article |
| id | doaj.art-1ae04e74d16e47b0aff414624ff50f37 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-09T17:14:02Z |
| publishDate | 2022-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-1ae04e74d16e47b0aff414624ff50f372023-11-24T13:47:15ZengMDPI AGCancers2072-66942022-12-011424616010.3390/cancers14246160Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. <i>Cancers</i> 2022<i>, 14</i>, 4265Matteo Ponzo0Anais Debesset1Mélissande Cossutta2Mounira Chalabi-Dchar3Claire Houppe4Caroline Pilon5Alba Nicolas-Boluda6Sylvain Meunier7Fabio Raineri8Allan Thiolat9Rémy Nicolle10Federica Maione11Serena Brundu12Carina Florina Cojocaru13Philippe Bouvet14Corinne Bousquet15Florence Gazeau16Christophe Tournigand17José Courty18Enrico Giraudo19José L. Cohen20Ilaria Cascone21Immune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceCancer Research Center of Lyon, Cancer Cell Plasticity Department, University of Lyon, UMR INSERM 1052 CNRS 5286, Centre Léon Bérard, F-69008 Lyon, FranceImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceMatières et Systèmes Complexes (MSC), Université de Paris, CNRS UMR 7057, F-75006 Paris, FranceImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceProgramme Cartes d’Identité des Tumeurs (CIT), Ligue Nationale Contre le Cancer, F-75013 Paris, FranceLaboratory of Tumor Microenvironment, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, ItalyLaboratory of Tumor Microenvironment, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, ItalyLaboratory of Tumor Microenvironment, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, ItalyMatières et Systèmes Complexes (MSC), Université de Paris, CNRS UMR 7057, F-75006 Paris, FranceUMR INSERM-1037, Cancer Research Center of Toulouse (CRCT), Toulouse University III, F-31037 Toulouse, FranceAP-HP, Groupe Hospitalo-Universitaire Chenevier Mondor, Centre D’investigation Clinique Biothérapie, F-94010 Créteil, FranceImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceLaboratory of Tumor Microenvironment, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, ItalyImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceImmune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, FranceIn the original publication [...]https://www.mdpi.com/2072-6694/14/24/6160n/a |
| spellingShingle | Matteo Ponzo Anais Debesset Mélissande Cossutta Mounira Chalabi-Dchar Claire Houppe Caroline Pilon Alba Nicolas-Boluda Sylvain Meunier Fabio Raineri Allan Thiolat Rémy Nicolle Federica Maione Serena Brundu Carina Florina Cojocaru Philippe Bouvet Corinne Bousquet Florence Gazeau Christophe Tournigand José Courty Enrico Giraudo José L. Cohen Ilaria Cascone Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. <i>Cancers</i> 2022<i>, 14</i>, 4265 Cancers n/a |
| title | Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. <i>Cancers</i> 2022<i>, 14</i>, 4265 |
| title_full | Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. <i>Cancers</i> 2022<i>, 14</i>, 4265 |
| title_fullStr | Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. <i>Cancers</i> 2022<i>, 14</i>, 4265 |
| title_full_unstemmed | Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. <i>Cancers</i> 2022<i>, 14</i>, 4265 |
| title_short | Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. <i>Cancers</i> 2022<i>, 14</i>, 4265 |
| title_sort | correction ponzo et al nucleolin therapeutic targeting decreases pancreatic cancer immunosuppression i cancers i 2022 i 14 i 4265 |
| topic | n/a |
| url | https://www.mdpi.com/2072-6694/14/24/6160 |
| work_keys_str_mv | AT matteoponzo correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT anaisdebesset correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT melissandecossutta correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT mounirachalabidchar correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT clairehouppe correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT carolinepilon correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT albanicolasboluda correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT sylvainmeunier correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT fabioraineri correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT allanthiolat correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT remynicolle correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT federicamaione correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT serenabrundu correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT carinaflorinacojocaru correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT philippebouvet correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT corinnebousquet correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT florencegazeau correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT christophetournigand correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT josecourty correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT enricogiraudo correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT joselcohen correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 AT ilariacascone correctionponzoetalnucleolintherapeutictargetingdecreasespancreaticcancerimmunosuppressionicancersi2022i14i4265 |